Literature DB >> 19775636

Lung cancer screening with low dose computed tomography: where do we stand today?

R J van Klaveren1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19775636     DOI： 10.1016/S0959-8049(09)70054-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma.

Authors:  Katerina Kachler; Corinna Holzinger; Denis I Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2018-04-25       Impact factor: 8.110

2.  Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.

Authors:  Isabel K Macdonald; Andrea Murray; Graham F Healey; Celine B Parsy-Kowalska; Jared Allen; Jane McElveen; Chris Robertson; Herbert F Sewell; Caroline J Chapman; John F R Robertson
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

3.  IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer.

Authors:  Lisanne Heim; Zuqin Yang; Patrick Tausche; Katja Hohenberger; Mircea T Chiriac; Julia Koelle; Carol-Immanuel Geppert; Katerina Kachler; Sarah Miksch; Anna Graser; Juliane Friedrich; Rakshin Kharwadkar; Ralf J Rieker; Denis I Trufa; Horia Sirbu; Markus F Neurath; Mark H Kaplan; Susetta Finotto
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

4.  Therapeutical measures to control airway tolerance in asthma and lung cancer.

Authors:  Katerina Andreev; Anna Graser; Anja Maier; Stephanie Mousset; Susetta Finotto
Journal:  Front Immunol       Date:  2012-07-26       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.